ASP Isotopes (NASDAQ:ASPI) Shares Gap Up - Here's Why

Key Points

• Shares gapped up premarket — the stock opened at $6.00 vs. a $5.63 close, last traded around $6.32 on ~1.71 million shares and was up roughly 16.4%.
• Analyst coverage is mixed: two Buy ratings and one Sell, with MarketBeat's consensus rating at "Hold" and an average price target of $13.00.
• Fundamentals show financial stress — negative EPS, a -1,259.12% net margin and -190.44% ROE (market cap ~$726.6M) — and insiders have been selling materially (528,091 shares sold over the last three months; insiders own 14.4%).

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) shares gapped up prior to trading on Monday . The stock had previously closed at $5.63, but opened at $6.00. ASP Isotopes shares last traded at $6.3160, with a volume of 1,708,767 shares changing hands.

Analyst Ratings Changes

ASPI has been the subject of a number of research reports. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of ASP Isotopes in a research note on Monday, December 29th. Cantor Fitzgerald initiated coverage on shares of ASP Isotopes in a research report on Thursday, December 4th. They issued an "overweight" rating and a $13.00 price target on the stock. Canaccord Genuity Group reissued a "buy" rating and set a $11.00 price objective on shares of ASP Isotopes in a research note on Monday, November 24th. Finally, Loop Capital set a $15.00 target price on ASP Isotopes in a report on Monday, October 27th. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $13.00.

ASP Isotopes Stock Up 16.4%

The company has a market cap of $726.56 million, a P/E ratio of -5.04 and a beta of 3.47. The firm's 50 day moving average price is $6.99 and its 200-day moving average price is $8.44. The company has a current ratio of 6.14, a quick ratio of 6.10 and a debt-to-equity ratio of 1.04.

ASP Isotopes (NASDAQ:ASPI - Get Free Report) last issued its quarterly earnings data on Wednesday, November 19th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.05). The business had revenue of $4.89 million during the quarter, compared to analyst estimates of $2.25 million. ASP Isotopes had a negative net margin of 1,259.12% and a negative return on equity of 190.44%. As a group, equities research analysts expect that ASP Isotopes Inc. will post -0.24 EPS for the current year.

Insider Activity at ASP Isotopes

In other news, CEO Robert Ainscow sold 67,500 shares of the business's stock in a transaction on Monday, November 17th. The stock was sold at an average price of $7.51, for a total transaction of $506,925.00. Following the completion of the transaction, the chief executive officer owned 1,579,693 shares of the company's stock, valued at approximately $11,863,494.43. The trade was a 4.10% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Heather Kiessling sold 80,000 shares of the firm's stock in a transaction on Thursday, December 18th. The stock was sold at an average price of $5.80, for a total value of $464,000.00. Following the transaction, the chief financial officer directly owned 732,500 shares of the company's stock, valued at approximately $4,248,500. This represents a 9.85% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 528,091 shares of company stock valued at $3,539,245 over the last three months. 14.40% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of ASPI. MetLife Investment Management LLC increased its position in shares of ASP Isotopes by 22.1% during the first quarter. MetLife Investment Management LLC now owns 31,732 shares of the company's stock valued at $149,000 after acquiring an additional 5,744 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of ASP Isotopes by 9.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 31,613 shares of the company's stock valued at $148,000 after purchasing an additional 2,709 shares during the last quarter. Rhumbline Advisers raised its stake in shares of ASP Isotopes by 8.2% during the 1st quarter. Rhumbline Advisers now owns 65,326 shares of the company's stock worth $306,000 after purchasing an additional 4,963 shares during the period. Exchange Traded Concepts LLC bought a new stake in shares of ASP Isotopes during the 2nd quarter worth $9,593,000. Finally, Harbour Capital Advisors LLC bought a new stake in shares of ASP Isotopes during the 2nd quarter worth $232,000. Institutional investors own 16.80% of the company's stock.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.